Early research (Phase 1)Study completedNCT03627754What this trial is testingEvaluate the Effect of Hepatic Impairment on the Pharmacokinetics of GlasdegibWho this might be right forHepatic Impairment Pfizer 24
Early research (Phase 1)Study completedNCT00969813What this trial is testingA Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic FunctionWho this might be right forHepatic Insufficiency Pfizer 18
Early research (Phase 1)Study completedNCT02894385What this trial is testingEffect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)Who this might be right forPharmacokineticsHepatic InsufficiencyRenal Insufficiency Bayer 29
Not applicableStudy completedNCT00825617What this trial is testingQuantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement TherapyWho this might be right forTurner Syndrome University of Aarhus 16
Large-scale testing (Phase 3)UnknownNCT03578055What this trial is testingBDD With UDCA Therapy After Laparoscopic CholecystectomyWho this might be right forCholecystitis, AcuteCholecystitis, Chronic Ewha Womans University Mokdong Hospital 172
Early research (Phase 1)Looking for participantsNCT07519135What this trial is testingLearn About the Medicine Called PF-08653944 in People With and Without Reduced Liver FunctionWho this might be right forHealthy Pfizer 26
Early research (Phase 1)Study completedNCT05283915What this trial is testingStudy to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic FunctionWho this might be right forHepatic Function Abnormal Sanofi 10
Early research (Phase 1)Study completedNCT05517525What this trial is testingEvaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic ImpairmentWho this might be right forHepatic Impairment Insmed Incorporated 30
Not applicableStudy completedNCT04698148What this trial is testingEstablishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal DiseasesWho this might be right forClostridium Difficile InfectionMulti Drug Resistant OrganismsChronic Inflammatory Bowel Disease+2 more Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 225
Not applicableStudy completedNCT03386435What this trial is testingThe Effect of Remote Ischemic Preconditioning in Living Donor HepatectomyWho this might be right forTissue DonorsLiver TransplantationIschemia Reperfusion Injury Asan Medical Center 160
Post-approval studies (Phase 4)Study completedNCT01588418What this trial is testingAcute Effect of Exenatide on Brain Glucose MetabolismWho this might be right forImpaired Glucose Tolerance (IGT)Diabetes The University of Texas Health Science Center at San Antonio 15
Not applicableStudy completedNCT03140917What this trial is testingMultimodal Assessment of Liver Volume and FunctionWho this might be right forColorectal CancerLiver Metastases Karolinska University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT04522908What this trial is testingDose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver FunctionWho this might be right forHepatocellular Carcinoma (HCC)Second Line Treatment Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 40
Early research (Phase 1)Study completedNCT07625618What this trial is testingA Pharmacokinetic and Safety Study of MY008211A Tablets in Subjects With Impaired or Normal Hepatic FunctionWho this might be right forHepatic Insufficiency (MeSH ID: D048550) Wuhan Createrna Science and Technology Co., Ltd 24
Early research (Phase 1)Study completedNCT01764776What this trial is testingEffect of Hepatic Impairment on LDE225..Who this might be right forNormal Hepatic FunctionImpaired Hepatic Function Novartis Pharmaceuticals 33
Early research (Phase 1)Study completedNCT03626415What this trial is testingA Hepatic Impairment Study for PF-04965842.Who this might be right forHepatic Impairment Pfizer 24
Early research (Phase 1)Looking for participantsNCT06997276What this trial is testingEffect of Hepatic Impairment on the Pharmacokinetics of MirdametinibWho this might be right forHealthyHepatic Impairment SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 32
Early research (Phase 1)WithdrawnNCT03912350What this trial is testingThe Effect of Hepatic Impairment on the Pharmacokinetics of BalovaptanWho this might be right forAutism Spectrum Disorder Hoffmann-La Roche
Post-approval studies (Phase 4)Study completedNCT00402571What this trial is testingHepatic Function During and Following Three Days of Acetaminophen Dosing in AlcoholicsWho this might be right forAlcohol Related Disorders Denver Health and Hospital Authority 420
Large-scale testing (Phase 3)UnknownNCT02093650What this trial is testingBlack Cohosh Extract for Treatment of Moderate to Severe Menopausal SymptomsWho this might be right forMenopauseQuality of Life Navamindradhiraj University 60